Establishing a pathological diagnosis in degenerative dementias

Area of Science:

• Neuropathology
• Neurodegenerative Diseases
• Dementia Diagnostics

Background:

• Alzheimer's disease (AD) is the most common cause of dementia, but other neurodegenerative pathologies also cause significant cognitive decline.
• Current pathological assessment of non-AD neurodegenerative diseases requires costly immunohistochemical techniques.
• A need exists for an efficient diagnostic scheme for differentiating various causes of dementia.

Purpose of the Study:

• To develop and present a staged examination scheme for brain tissue to diagnose neurodegenerative dementias.
• To differentiate Alzheimer's disease from other non-Alzheimer neurodegenerative conditions.
• To establish a cost-effective diagnostic pathway for cognitive decline.

Main Methods:

• A staged examination scheme for brain tissue analysis.
• Initial screening using conventional staining and established protocols for Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.
• Immunohistochemical techniques to discriminate between non-Alzheimer degenerative dementias, including frontotemporal dementia and prion disease.

Main Results:

• The proposed scheme efficiently screens for common dementias like Alzheimer's disease (AD).
• Immunohistochemistry is crucial for distinguishing between various non-Alzheimer degenerative dementias.
• Specific markers like ubiquitin, tau protein, alpha beta crystallin, and prion protein aid in diagnosing frontotemporal dementia and prion disease, respectively.

Conclusions:

• The staged examination scheme provides an effective method for diagnosing neurodegenerative dementias.
• This approach optimizes the use of costly immunohistochemical techniques by employing them selectively.
• Morphological assessment, complemented by genetic insights, enhances the diagnosis of complex neurodegenerative diseases.